Press Releases
Feb. 10, 2026
TerrAscend to Host Fourth Quarter and Full Year 2025 Earnings Conference Call
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
Daily Session Report for Wednesday, February 04, 2026
Gov't Institution
Pennsylvania General Assembly
Feb. 9, 2026
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
Why Leading Sauna Contractors Are Adding Red Light Therapy to Custom and Commercial Saunas.
Neutral
EIN Presswire
Feb. 10, 2026
The Counseling Center Data Breach Claims Investigated by Lynch Carpenter
Indeterminate
GlobeNewswire, Inc.
Feb. 10, 2026
Krystal Biotech to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
Indeterminate
GlobeNewswire, Inc.
Feb. 9, 2026
Daily Session Report for Tuesday, February 03, 2026
Gov't Institution
Pennsylvania General Assembly
Feb. 11, 2026
Hugo Neu Corporation Appoints Michael Meyer as President of Hugo Neu Realty Management – Kearny Point
Indeterminate
GlobeNewswire, Inc.
Feb. 10, 2026
Mannik & Smith Group, Inc. Selects Locus Technologies to Power Advanced Environmental Data Management and Compliance
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
Attorney General James Urges Congress to Pass Senate’s Kids Online Safety Act
Gov't Institution
New York Attorney General
Owner: American Government
Feb. 11, 2026
Lincoln Tech Brings Career Training Opportunities to Levittown, PA
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
Blueclone Networks Introduces Email Security Best Practices Guide to Protect Businesses from Email Compromise
Neutral
EIN Presswire
Feb. 9, 2026
Chapman & Associates Data Breach Claims Investigated by Lynch Carpenter
Indeterminate
GlobeNewswire, Inc.
Feb. 5, 2026
Senate Resolution 220 Printer's Number 1429
Gov't Institution
Pennsylvania General Assembly
Feb. 9, 2026
Michael J. Bercik Jr., MD Performed Over 125 Shoulder Replacements in 2025, Ranking in Top 1% Nationally
Neutral
EIN Presswire
Feb. 9, 2026
Top-Performing 2026 Construction Companies Named by ABC
Indeterminate
GlobeNewswire, Inc.
Feb. 6, 2026
Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)
Indeterminate
GlobeNewswire, Inc.